New point of attack for breast cancer with poor prognosis
(Medical Xpress) -- Scientists from the Friedrich Miescher Institute for Biomedical Research describe how the protein phosphatase SHP2 promotes breast cancer with poor prognosis. As they report in the latest ...
Cancer
Mar 05, 2012 |
5 / 5 (2) |
0
|
A two-pronged attack: Why loss of STAT1 is bad news
Breast cancer represents about a fifth of all cancers diagnosed in women. The reasons for the rapid progression of the disease remain relatively poorly understood but recent work in the group of Veronika Sexl at the University ...
Cancer
Feb 29, 2012 |
not rated yet |
0
Researchers uncover new operations of cancer suppressor
(Medical Xpress) -- Scientists at the University of Dundee studying an important tumour suppressor, which is involved in at least a quarter of all cancers, have uncovered new ways in which it works.
Cancer
Feb 24, 2012 |
5 / 5 (1) |
0
High VEGF signaling score tied to lung cancer prognosis
(HealthDay) -- A high vascular endothelial growth factor (VEGF) signaling score correlates with good prognosis in patients with early squamous cell carcinoma (SCC) of the lung, according to a study published ...
Cancer
Feb 22, 2012 |
5 / 5 (1) |
0
Mammography-detected breast cancer in 40-49 year-olds has better prognosis
Based on a study of nearly 2,000 breast cancer patients, researchers at the Swedish Cancer Institute in Seattle say that, in women between the ages of 40 and 49, breast cancers detected by mammography have a better prognosis. ...
Cancer
Feb 22, 2012 |
not rated yet |
0
Evidence strengthens link between NSAIDs and reduced cancer metastasis
A new study reveals key factors that promote the spread of cancer to lymph nodes and provides a mechanism that explains how a common over-the-counter anti-inflammatory medication can reduce the spread of tumor cells through ...
Cancer
Feb 13, 2012 |
5 / 5 (2) |
0
Enhancing the effectiveness of a breast cancer treatment
Breast cancers expressing the protein HER2 have a particularly poor prognosis. Treatment with trastuzumab (Herceptin) benefits some patients with HER2-positive breast cancer, but it is not as effective as had been hoped. ...
Cancer
Feb 13, 2012 |
5 / 5 (1) |
0
Study finds MDs not always honest with patients
(AP) -- Trust your doctor? A survey finds that some doctors aren't always completely honest with their patients.
Health
Feb 08, 2012 |
not rated yet |
1
ASTRO develops brain metastases guideline
The American Society for Radiation Oncology (ASTRO) has developed a guideline on the radiotherapeutic and surgical management for newly diagnosed brain metastases. It has been published in Practical Radiation Oncology (PRO), ...
Cancer
Feb 08, 2012 |
not rated yet |
0
Balancing oxaliplatin dose with neurological side effects in metastatic colon cancer
The drug oxaliplatin is a major reason the prognosis for metastatic colon cancer has gone from an expected survival of several months to a couple years. Unfortunately, the drug can also carry with it debilitating neurological ...
Cancer
Feb 02, 2012 |
5 / 5 (1) |
0
A thought-provoking new therapeutic target for brain cancer?
Glioblastoma multiforme (GBM) is the most common of all malignant brain tumors that originate in the brain. Patients with GBM have a poor prognosis because it is a highly aggressive form of cancer that is commonly resistant ...
Cancer
Feb 01, 2012 |
not rated yet |
0
New lung cancer test predicts survival
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available ...
Cancer
Jan 26, 2012 |
4.8 / 5 (5) |
0
|
New therapeutic target to combat liver cancer discovered
Spanish researchers at CIC Biogune, the Cooperative Centre for Research into Biosciences and led by Dr. Maria Luz Martinez Chantar, have found a strong relationship between high levels of Hu antigen R (HuR) protein and the ...
Cancer
Jan 26, 2012 |
not rated yet |
0
Drug improves survival of colorectal cancer patients, trial results show
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented ...
Cancer
Jan 18, 2012 |
not rated yet |
0
Cell death researchers identify new Achilles heel in acute myeloid leukemia
Melbourne researchers have discovered that acute myeloid leukaemia (AML), an aggressive blood cancer with poor prognosis, may be susceptible to medications that target a protein called Mcl-1.
Genetics
Jan 17, 2012 |
5 / 5 (1) |
0
